Viewing Study NCT01907750


Ignite Creation Date: 2025-12-24 @ 4:49 PM
Ignite Modification Date: 2026-02-20 @ 3:44 AM
Study NCT ID: NCT01907750
Status: UNKNOWN
Last Update Posted: 2016-03-01
First Post: 2013-06-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Transcystic Versus Transanastomotic Tube Drainage in Right Lobe LDLT
Sponsor: Mansoura University
Organization:

Study Overview

Official Title: Transcystic Versus Transanastomotic Biliary Drainage Tubes in Living Donor Liver Transplantation. A Prospective Randomized Trial.
Status: UNKNOWN
Status Verified Date: 2016-02
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To evaluate the safety and effectiveness of the use of transcystic biliary drainage tube (not transanastomotic) in comparison to the usual transanastomotic biliary drainage tube.
Detailed Description: a biliary drainage tube is usually inserted into the biliary passage after choledocho-choledochostomy (bile duct to bile duct joining).

A 4F or 5F biliary catheter (Marquat Genie biomedical, france) is used in all cases.

the study is to compare the effectiveness and safety of 2 different placement techniques:

1. the usual trans-anastomotic position (the tube is placed across the anastomosis line with the tip inside the intrahepatic biliary branches) through an opening in the wall of the recipient's common bile duct
2. a transcystic non-anastomotic position (the tube is placed through the cystic duct opening into the distal common bile duct not passing through anastomosis)

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: